Binuclear [Cu(bipyridine)(NO3)(OH)]2 complex: Structural characterization, DFT calculations, molecular docking, and cytotoxicity against breast adenocarcinoma cells
Source abstract
Abstract
Copper(II) complexes with aromatic N-heterocyclic ligands have attracted considerable attention as potential anticancer agents due to their capacity to interact with DNA and inhibit tumor cell proliferation. Despite the structural characterization of the binuclear [Cu(Bipyridine)(NO 3 )(OH)] 2 complex reported nearly three decades ago, its physicochemical and biological landscape remained largely unexplored. In the present work, a comprehensive characterization of this complex is reported, encompassing experimental and computational approaches. The complex was synthesized by slow solvent evaporation and confirmed by powder X-ray diffraction (PXRD) with Rietveld refinement, which established a triclinic structure (space group , Z = 1) with lattice parameters in good agreement with literature values (ΔV = 0.44%). Ultraviolet-visible spectroscopy revealed a d-d transition at 641 nm, from which a crystal field splitting parameter of 10Dq ≈ 15,601 cm –1 was estimated, confirming the stronger ligand field of 2,2-bipyridine relative to water. Density functional theory (DFT) calculations using the PBE1PBE functional in vacuum, water, and methanol revealed the triplet state as the most stable configuration and demonstrated a solvation-dependent increase in the HOMO-LUMO gap (3.40 eV in vacuum; 4.65 eV in water), reflecting enhanced electronic stability under physiological conditions. High electrophilicity values ( ϖ = 5.05-5.51 eV) support the potential for interactions with biological nucleophiles. Hirshfeld surface analysis quantified the dominant intermolecular interactions in the crystal lattice, with H···O/O···H contacts accounting for 41.1% of the surface. A group-theory-based normal mode analysis provided suitable assignment of the observed modes, with strong agreement between experimental and DFT-calculated spectra. Thermal analysis demonstrated stability up to 473 K, confirmed by variable-temperature PXRD up to 620 K. Molecular docking revealed affinity for DNA ( K i = 6.27 μM, PDB: 1BNA) and the breast cancer-associated 3α-hydroxysteroid dehydrogenase type 3 enzyme ( K i = 36.69 μM, PDB: 4XO6). In silico pharmacokinetics profiling indicated limited oral bioavailability due to high topological polar surface area (TPSA = 169.18 Å 2 ), though favorable water solubility (Log S = 0.31) and absence of CYP450 inhibition suggest low hepatotoxicity risk. Cytotoxicity assays yielded IC 50 values of 39.73 μM and 14.46 μM against MCF-7 breast adenocarcinoma and GM07492A healthy fibroblast cell lines, respectively, with a selectivity index of 0.36. These results establish [Cu(Bipyridine)(NO 3 )(OH)] 2 as a biologically relevant binuclear Cu(II) candidate whose tumor selectivity may be improved through targeted nanoencapsulation strategies.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Metal complexes synthesis and properties · Metal-Organic Frameworks: Synthesis and Applications · Crystal structures of chemical compounds
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (95)
Show source-provided references
1. Ruthenium metallopharmaceuticals10.1016/S0010-8545(02)00312-0 ↗
2. Interactions of Metal−Metal-Bonded antitumor active complexes with DNA fragments and DNA10.1021/ar0302078 ↗
3. Mixed-Ligand Copper(II)-phenolate complexes: effect of coligand on enhanced DNA and protein binding, DNA cleavage, and anticancer activity10.1021/ic700755p ↗
4. Experimental and computational study of Ni(II) and Zn(II) complexes of isatin-3-thiosemicarbazone: structure, biological activity and ct-DNA binding study10.1016/j.molstruc.2025.141846 ↗
5. Metallodrugs: synthesis, mechanism of action and nanoencapsulation for targeted chemotherapy10.1016/j.bcp.2024.116644 ↗
6. Synthesis, crystal structure, cytotoxic activities and DNA-binding properties of new binuclear copper(II) complexes bridged by N,N′-bis(N-hydroxyethylaminoethyl)oxamide10.1016/j.jinorgbio.2009.02.007 ↗
7. Recognition and reaction of metallointercalators with DNA10.1021/cr9804341 ↗
8. Structure, recognition, and processing of Cisplatin−DNA adducts10.1021/cr980421n ↗
9. Synthesis, X-ray structure, vibrational spectroscopy, DFT, biological evaluation and molecular docking studies of (E)-N′-(4-(dimethylamino)benzylidene)-5-methyl-1H-pyrazole-3-carbohydrazide10.1016/j.molstruc.2020.128541 ↗
10. Synthesis, characterization and DNA-binding studies of cobalt(III) polypyridyl complexes10.1016/S0277-5387(01)00924-X ↗
11. Effects of ligand planarity on the interaction of polypyridyl Ru(ii) complexes with DNA10.1039/b300353a ↗
12. Effects of the ancillary ligands of polypyridyl ruthenium(ii) complexes on the DNA-binding behaviors10.1039/b212826h ↗
13. Thermodynamic and spectroscopic study on the binding of cationic Zn(ii) and Co(ii) tetrapyridinoporphyrazines to calf thymus DNA: the role of the central metal in binding parameters10.1039/b404068f ↗
14. New binuclear Cu (II) complex: synthesis, structural elucidation, cytotoxic and DNA-binding evaluation10.1007/s11243-023-00561-8 ↗
15. Copper(II) complexes of terpyridine derivatives: a footstep towards development of antiproliferative agent for breast cancer10.1016/j.jinorgbio.2012.08.010 ↗
16. DNA hydrolysis promoted by di- and multi-nuclear metal complexes10.1016/j.cct.2003.11.002 ↗
17. Amphiphilic Cu(II) oxacyclen complexes: from oxidative cleavage to condensation of DNA10.1002/cbic.202500477 ↗
18. The effect of potential supramolecular-bond promoters on the DNA-interacting abilities of copper–terpyridine compounds10.1039/C5DT02211H ↗
19. Novel mononuclear Cu (II) terpyridine complexes: impact of fused ring thiophene and thiazole head groups towards DNA/BSA interaction, cleavage and antiproliferative activity on HepG2 and triple negative CAL-51 cell line10.1016/j.ejmech.2017.04.030 ↗
20. Synthesis, cytotoxic activity and DNA-binding properties of copper(II) complexes with terpyridine10.1016/j.poly.2017.11.008 ↗
21. DNA and BSA binding and cytotoxic properties of copper(ii) and iron(iii) complexes with arylhydrazone of ethyl 2-cyanoacetate or formazan ligands10.1039/C7NJ00420F ↗
22. Copper(II) mixed chelate compounds induce apoptosis through reactive oxygen species in neuroblastoma cell line CHP-21210.1016/j.jinorgbio.2013.05.001 ↗
23. Isomeric effect on the pharmacokinetic behavior of anticancer CuII mixed chelate complexes: experimental and theoretical approach
24. Design, synthesis, and evaluation of benzimidazole-carbazole hybrids targeting heat shock proteins-mediated apoptosis in breast and Colon cancer cells10.1002/ddr.70092 ↗
25. Discovery of sulfadrug–pyrrole conjugates as carbonic anhydrase and acetylcholinesterase inhibitors10.1002/ardp.202100242 ↗
26. Efficient enhancement of DNA cleavage activity by introducing guanidinium groups into diiron(III) complex10.1016/j.bmcl.2007.11.001 ↗
27. Physical and kinetic analysis of the cooperative role of metal ions in catalysis of phosphodiester cleavage by a dinuclear Zn(II) complex10.1021/ja027728v ↗
28. Theoretical, biological and in silico studies of pendant-armed heteroleptic copper(II) phenolate complexes10.1016/j.molstruc.2018.02.025 ↗
29. Synthesis, nucleic acid binding and cytotoxicity of polyethyleneimine-copper(II) complexes containing 1,10-phenanthroline and l-valine10.1016/j.ejmech.2011.04.033 ↗
30. Rhenium(I) tricarbonyl complexes of 1,10-Phenanthroline derivatives with unexpectedly high cytotoxicity10.1021/acs.inorgchem.3c00730 ↗
31. The 1,10-Phenanthroline ligand enhances the antiproliferative activity of DNA-Intercalating Thiourea-Pd(II) and -Pt(II) complexes against cisplatin-sensitive and -Resistant human ovarian cancer cell lines10.3390/ijms20246122 ↗
32. Copper(II) and silver(I)-1,10-phenanthroline-5,6-dione complexes interact with double-stranded DNA: further evidence of their apparent multi-modal activity towards Pseudomonas aeruginosa10.1007/s00775-021-01922-3 ↗
33. The chemistry of dinitrato-2, 2′-bipyridinecopper(II): preparation and characterization of binuclear complexes having a Cu(μ-OH)2Cu and Cu(μ-N3)2Cu core10.1016/S0020-1693(98)00007-3 ↗
34. Two novel copper complexes of 2,2′-bipyridine: evaluation of the DNA binding and cytotoxic activity10.1016/j.jphotobiol.2013.04.011 ↗
35. EXPGUI, a graphical user interface for GSAS10.1107/S0021889801002242 ↗
36. Quantum mechanical Continuum Solvation models10.1021/cr9904009 ↗
37. Spin propensities of octahedral complexes from density functional theory10.1021/acs.jpca.5b01626 ↗
38. Frisch · 2016
39. Thirty years of density functional theory in computational chemistry: an overview and extensive assessment of 200 density functionals10.1080/00268976.2017.1333644 ↗
40. An evaluation of harmonic vibrational frequency Scale factors10.1021/jp073974n ↗
41. Improving vibrational mode interpretation using bayesian regression10.1021/acs.jctc.8b00439 ↗
42. Morris · 2009 · vol. 30 · 2785
43. Structure of a B-DNA dodecamer: conformation and dynamics10.1073/pnas.78.4.2179 ↗
44. Drew · 1981
45. Human 3α-hydroxysteroid dehydrogenase type 3: structural clues of 5α-DHT reverse binding and enzyme down-regulation decreasing MCF7 cell growth10.1042/BCJ20160083 ↗
46. Novel Bromo and methoxy substituted Schiff base complexes of Mn(II), Fe(III), and Cr(III) for anticancer, antimicrobial, docking, and ADMET studies10.1038/s41598-023-29386-2 ↗
47. Design, synthesis, and characterization of M(II)-Schiff base complexes containing 3,5-di-tert-butyl salicylaldehyde: DNA binding/cleavage, DPPH radical scavenging activity, cytotoxic activity, and catalytic activity investigation
48. 3D computer modeling of inhibitors targeting the MCF-7 breast cancer cell line10.3389/fchem.2024.1384832 ↗
49. Investigation on chloro-bridged binuclear copper(II) complexes as potent metallodrug candidates against colon cancer via chemical and biological assessments10.1039/D3NJ05335K ↗
50. Anti-asthmatic effect of nitric oxide metallo-donor FOR8111A [cis-[Ru(bpy)2(2-MIM)(NO)](PF6)3] in the respiratory mechanics of Swiss mice10.1371/journal.pone.0248394 ↗
51. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules10.1038/srep42717 ↗
52. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings10.1016/S0169-409X(96)00423-1 ↗
53. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases10.1021/cc9800071 ↗
54. Molecular properties that influence the oral bioavailability of drug candidates10.1021/jm020017n ↗
55. Prediction of drug absorption using multivariate statistics10.1021/jm000292e ↗
56. Jones · 2001
57. Novel copper(II) complexes with hydrazides and heterocyclic bases: synthesis, structure and biological studies10.1016/j.jinorgbio.2017.04.024 ↗
58. Synthesis, physicochemical properties, DFT calculations, molecular docking, and antibacterial profile of copper crystals complexed with 1,10-phenanthroline and L-asparagine10.1016/j.molliq.2025.129145 ↗
59. The ligand field Spectra of Copper(II) complexes10.1021/ed075p98 ↗
60. A single crystal hybrid ligand framework of Copper(II) with stable intrinsic blue-light luminescence in aqueous solution10.3390/nano11092281 ↗
61. Synthesis, spectrophotometric and DFT studies of new Triazole Schiff bases as selective naked-eye sensors for acetate anion10.1080/10610278.2020.1808217 ↗
62. Vibrational spectroscopy (FT-IR and FT-Raman) investigation, and hybrid computational (HF and DFT) analysis on the structure of 2,3-naphthalenediol10.1016/j.saa.2011.09.002 ↗
63. Mixed-ligand cobalt(II) complexes of bioinorganic and medicinal relevance, involving dehydroacetic acid and β-diketones: their synthesis, hyphenated experimental-DFT, thermal and bactericidal facets10.1016/j.molstruc.2015.06.019 ↗
64. Corrosion inhibition of carbon steel in 1 M H2SO4 using new Azo Schiff compound: electrochemical, gravimetric, adsorption, surface and DFT studies10.1016/j.molliq.2020.113690 ↗
65. Recent advances in the discovery of copper(II) complexes as potential anticancer drugs10.1016/j.ejmech.2025.117702 ↗
66. Quantum chemical properties investigation and molecular docking analysis with DNA topoisomerase II of β-carboline indole alkaloids from Simaba guianensis: a combined experimental and theoretical DFT study10.1007/s11224-017-1029-5 ↗
67. Magnetic property, DFT calculation, and biological activity of bis[(μ2-chloro)chloro(1,10-phenanthroline)copper(II)] complex10.1016/j.cbi.2015.02.023 ↗
68. Generalized koopmans' Theorem10.1103/PhysRev.123.420 ↗
69. On Koopmans' theorem in density functional theory10.1063/1.3491272 ↗
70. Density functional theory studies on copper phenanthroline complexes10.1021/ic0618908 ↗
71. Electronegativity: the density functional viewpoint10.1063/1.436185 ↗
72. Molecular structures, spectroscopic (FT–IR, NMR, UV) studies, NBO analysis and NLO properties for tautomeric forms of 1,3-dimethyl-5-(phenylazo)-6-aminouracil by density functional method10.1016/j.saa.2017.07.034 ↗
73. Electrophilicity index as a possible descriptor of biological activity10.1016/j.bmc.2004.08.013 ↗
74. Experimental and computational approaches of a novel methyl (2E)-2-{[N-(2-formylphenyl)(4-methylbenzene)sulfonamido]methyl}-3-(4-chlorophenyl)prop-2-enoate: A potential antimicrobial agent and an inhibition of penicillin-binding protein10.1016/j.molstruc.2016.02.084 ↗
75. Hirshfeld surface analysis10.1039/B818330A ↗
76. Copper(II) and zinc(II) complexes with hydrazone: synthesis, crystal structure, hirshfeld surface and antibacterial activity10.1016/j.ica.2020.119632 ↗
77. Normal mode determination in crystals10.1002/jrs.1250100152 ↗
78. The infrared spectra (4000–50 cm−1) of complexes of 2,2′-Bipyridine, 1,10-Phenanthroline and their perdeuterated analogues with Metal(II) perchlorates of the first transition series10.1080/00958979209409204 ↗
79. Normal mode analysis of 2,2′-bipyridine—I. Internal modes10.1016/0584-8539(83)80063-4 ↗
80. Normal mode analysis of 2,2′-bipyridine—II. Crystal vibrations10.1016/0584-8539(83)80064-6 ↗
81. IR and Raman spectra of 2,2'-bipyridine10.1016/0301-0104(79)85204-0 ↗
82. Copper(II):phenanthroline complexes with l-asparagine and l-methionine: synthesis, crystal structure and in-vitro cytotoxic effects on prostate, breast and melanoma cancer cells10.1016/j.poly.2020.114807 ↗
83. Synthesis, characterization, DFT study, and antibacterial activity of a coordination complex of Cu(II) with 1,10-phenanthroline and l-methionine ligands10.1016/j.molstruc.2023.136197 ↗
84. Antibacterial [Zn(nicotinamide)2Cl2] complex for the treatment of skin conditions: an experimental-theoretical study of physicochemical, microbiological and in silico pharmacokinetic properties10.1016/j.molliq.2024.124846 ↗
85. Exploring thermal stability, vibrational properties, and biological assessments of Dichloro(l-histidine)copper(II): a combined theoretical and experimental study10.1021/acsomega.4c05029 ↗
86. (+)-Limonene 1,2-Epoxide-Loaded SLNs: evaluation of drug release, antioxidant activity, and cytotoxicity in an HaCaT cell line10.3390/ijms21041449 ↗
87. Interaction between chiral ions: synthesis and characterization of tartratovanadates(V) with tris(2,2′-bipyridine) complexes of iron(II) and nickel(II) as cations10.1007/s11243-014-9873-2 ↗
88. Preparation, characterization, and kinetics of thermolysis of nickel and copper nitrate complexes with 2,2′-bipyridine ligand10.1016/j.tca.2012.06.032 ↗
89. Discrete terpyridine-lanthanide molecular and supramolecular complexes10.1016/j.supmat.2022.100017 ↗
90. Thermal behaviour of the N-donor adducts of metal Saccharinates: I. 2,2'-bipyridine saccharinato complexes of Co(II), Ni(II), Cu(II), Zn(II) and Pb(II)10.1023/A:1011516316158 ↗
91. Zhang · 2024
92. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties10.1021/jm000942e ↗
93. Structural, vibrational, thermal, and cytotoxic characterization of Aqua(1,10-Phenanthroline)(L-Serinato)Copper(II) nitrate complex combined with DFT calculations10.1002/crat.202300240 ↗
94. Copper(II) complexes based on thiosemicarbazone ligand: preparation, crystal structure, Hirshfeld surface, energy framework, antiMycobacterium activity, in silico and molecular docking studies10.1016/j.jinorgbio.2021.111543 ↗
95. Synthesis, spectroscopic characterization, thermal stability and biological studies of mixed ligand complexes of gemifloxacin drug and 2,2′-bipyridine with some transition metals10.1007/s11164-015-2205-0 ↗